 ultrasound-guided foam
sclerotherapy (UGFS), physician compounded foam
sclerotherapy, or commercially produced foam sclerotherapy. We also studied patients (only CEAP class C2)
who underwent ablation of incompetent perforating
veins. We included studies that enrolled at least 85% of
the population of interest (ie, if 85% of the population of
the study Ô¨Åts the question of the systematic review, for
example,